The online version of this article (doi:10.1186/1477-7819-10-97) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
SW has contributed to the conception and design of the study, the analysis and interpretation of data, the revision of the article as well as final approval of the version to be submitted. WZ, QD and XL participated in the design of the study, performed the statistical analysis, drafted and revised the article. WZ, LC, and TX performed the experimental study; YJ performed the MRI. YZ performed the histopathological examinations. All authors read and approved the final version of the manuscript.
Percutaneous microwave coagulation (PMC) has been accepted as a promising modality in the treatment of tumors in well-vascularized tissues such as liver tumors and hysteromyoma. However, PMC for treatment of tumors in low blood-flow tissues has been seldom reported. The aim of this study was to determine the feasibility and safety of PMC for the treatment of tumors in low blood-flow tissues in a rabbit model.
Fifteen rabbits with VX2 tumors implanted subcutaneously underneath the right second nipple were divided into a PMC group (n = 9) and a control group (n = 6). PMC was performed with output power of 40 W for one to two minutes. The therapeutic efficacy was evaluated by magnetic resonance imaging (MRI), physical examinations, survival rate, and histology. The cosmetic outcome after PMC was also assessed.
In the PMC group, tumor eradication was achieved in six rabbits (66.7%) without any evidence of tumor recurrence and metastasis as proven by MRI and histological examinations. The mean greatest and shortest tumor diameters of these six rabbits were 1.83 and 1.33 cm, respectively. Slight epidermal burns, which proved reversible, were found in seven rabbits (77.8%). The PMC group had a significantly longer survival than those in the control group (P = 0.0097). The four rabbits with coagulated tumors survived more than three months with their tumors becoming nonpalpable and undetectable by MRI and histological examinations.
PMC is feasible and safe in the treatment of tumors in low blood-flow tissues in a rabbit model. Attention should be paid to avoid skin burns with PMC.
Authors’ original file for figure 112957_2012_1031_MOESM1_ESM.tiff
Authors’ original file for figure 212957_2012_1031_MOESM2_ESM.tiff
Authors’ original file for figure 312957_2012_1031_MOESM3_ESM.tiff
Authors’ original file for figure 412957_2012_1031_MOESM4_ESM.tiff
Authors’ original file for figure 512957_2012_1031_MOESM5_ESM.tiff
Jiao D, Qian L, Zhang Y, Zhang F, Li C, Huang Z, Zhang L, Zhang W, Wu P, Han X, Duan G, Han J: Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol. 2010, 136: 1507-1516. 10.1007/s00432-010-0808-9. CrossRefPubMed
Morikawa S, Naka S, Murakami K, Kurumi Y, Shiomi H, Tani T, Haque HA, Tokuda J, Hata N, Inubushi T: Preliminary clinical experiences of a motorized manipulator for magnetic resonance image-guided microwave coagulation therapy of liver tumors. Am J Surg. 2009, 198: 340-347. 10.1016/j.amjsurg.2009.02.006. CrossRefPubMed
Yeasmin S, Nakayama K, Ishibashi M, Katagiri A, Iida K, Nakayama N, Aoki S, Kanaoka Y, Miyazaki K: Microwave endometrial ablation as an alternative to hysterectomy for the emergent control of uterine bleeding in patients who are poor surgical candidates. Arch Gynecol Obstet. 2009, 280: 279-282. 10.1007/s00404-008-0885-z. PubMedCentralCrossRefPubMed
Fujimoto S, Kobayashi K, Takahashi M, Nemoto K, Yamamoto I, Mutou T, Toyasawa T, Ashida T, Hayashi S, Igarashi N, Ohkubo H: Clinical pilot studies on pre-operative hyperthermic tumour ablation for advanced breast carcinoma using an 8 MHz radiofrequency heating device. Int J Hyperthermia. 2003, 19: 13-22. 10.1080/0265673021000017073. CrossRefPubMed
Tanaka T, Westphal S, Isfort P, Braunschweig T, Penzkofer T, Bruners P, Kichikawa K, Schmitz-Rode T, Mahnken AH: Microwave Ablation Compared with Radiofrequency Ablation for Breast Tissue in an Ex Vivo Bovine Udder Model. Cardiovasc Intervent Radiol. 2012, in press
Wissniowski TT, Hansler J, Neureiter D, Frieser M, Schaber S, Esslinger B, Voll R, Strobel D, Hahn EG, Schuppan D: Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res. 2003, 63: 6496-6500. PubMed
Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, Botti G, D’Aiuto G, Cortino P, Curley SA: Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer. 2001, 92: 2036-2044. 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W. CrossRefPubMed
Boehm T, Malich A, Nahum Goldberg S, Reichenbach JR, Hilger I, Fleck M, Kaiser WA: Vacuum-assisted resection of malignant tumors with and without subsequent radiofrequency ablation: feasibility of complete tumor treatment tested in an animal model. J Vasc Interv Radiol. 2001, 12: 1086-1093. 10.1016/S1051-0443(07)61596-6. CrossRefPubMed
- Percutaneous microwave coagulation for eradication of VX2 tumors subcutaneously in rabbits
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II